Gene Query: STARD4

Dataset Description Geneva Score
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 349.22
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 108.35
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 96.0
Ebola virus (EBOV) infection of ARPE-19 cells 79.06
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 64.01
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 60.41
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 52.21
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 51.05
Effect of PRDM11 depletion in U2932 cells 47.53
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 47.44
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 47.15
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 46.12
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 46.06
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 46.06
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 45.96
Genome wide expression change by RNF168 knocking down in NEC cells 44.72
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 44.55
RNA-seq of human fibroblasts after irradiation 43.91
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 42.37
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 42.32
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 42.32
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 41.67
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 41.5
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 41.01
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 40.56
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 38.34
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 38.34
RNA-seq analyisis of PUM2 knockout cells 36.07
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 35.93
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 35.93
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 34.05
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 33.62
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 33.36
Cell responses to dysregulated VZV-induced cell-cell fusion 32.66
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 32.46
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 32.46
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 31.21
G-quadruplex structures mark human regulatory chromatin 31.16
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 30.82
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 30.81
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 30.62
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 29.81
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 29.2
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 29.14
Hypoxic transcriptome of SQ20B human head and neck cancer cells 29.04
Molecular Mechanisms of Endothelial Hyperpermeability 28.35
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 28.28
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 27.87
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 27.75
Transcriptional responses of human insulinoma cells to acute cytokine exposure 27.29
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 27.23
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 27.16
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 26.65
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 26.6
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 26.34
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 26.33
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 26.33
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 26.03
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 25.7
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 25.7
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 25.64
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 25.47
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 25.42
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 24.96
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 24.96
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 24.96
KSDM1b Role in Ewing Sarcoma 24.86
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 24.66
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 24.51
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 24.51
Electronic cigarettes 24.42
Gene expression in PANC1 cells treated with Rakicidin 23.85
RNA expression following TMPRSS11B overexpression or depletion 23.71
Entrectinib Resistance in a Neuroblastoma Xenograft Model 23.6
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 23.59
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 23.33
RNA seq with AML (NB4) cells upon FTO inhibition 23.26
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 23.01
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 22.79
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 22.65
Dtx3L and Androgen Signaling in Prostate Cancer 22.51
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 22.49
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 22.45
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 22.33
Gene expression analysis of dengue-infected cells 22.17
Studying the selectivity of a small molecule Synucleozid on transcriptome 22.08
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 22.03
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 22.0
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 21.97
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 21.81
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 21.81
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 21.7
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 21.47
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 21.41
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 21.21
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 20.98
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 20.68
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 20.66
Transcriptomic analysis of LSD1 20.57
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 20.45
Knockdown of ADNP in HCT116 colon cancer cells 20.31
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 20.3
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 20.3
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 20.19
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 20.19
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 20.17
MYCL and EP400 are required for Max and MCPyV mediated gene activation 20.16
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 19.98
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 19.93
The comparison of high-throughput single-cell RNA-seq methods 19.78
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 19.66
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 19.63
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 19.63
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 19.61
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 19.4
Landscape of H3K4me3 in human CD19 cells 19.39
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 19.3
Selective expression of long non-coding RNAs in a breast cancer cell progression model 19.27
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 19.22
Functional role of SLIT2 and ROBO1 in trophoblasts 19.16
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 19.11
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 19.06
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 19.01
Effects of rFVIIIFc on human macrophages 18.95
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 18.91
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 18.81
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 18.67
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 18.67
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 18.6
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 18.53
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 18.53
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 18.51
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 18.35
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 18.21
Region-specific Innate Antiviral Responses of the Human Epididymis 18.11
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 18.04
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 18.0
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 18.0
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 17.99
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 17.98
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 17.88
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 17.87
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 17.81
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 17.79
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 17.64
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 17.59
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 17.51
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 17.43
Transcriptional profiling of LS1034 cells treated with tepoxalin 17.36
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 17.32
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 17.23
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 17.2
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 17.14
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 17.14
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 17.13
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 17.07
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 16.98
RNA-Seq from early time points in the kidney differentiation protocol 16.98
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 16.95
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 16.86
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 16.76
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 16.73
Real-time observation of light-controlled transcription in living cells 16.6
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 16.59
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 16.5
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 16.49
Differential gene expression of human melanoma cells [RNA-seq] 16.49
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 16.43
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 16.42
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 16.42
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 16.25
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 16.14
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 16.14
Sensing self and nonself circular RNAs 16.13
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 16.07
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 16.05
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 15.95
Transcriptome of activated human and mouse MAIT cells 15.83
Gene expression signatures of innate lymphoid cells from human blood 15.81
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 15.79
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 15.7
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 15.67
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 15.67
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 15.61
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 15.5
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 15.5
K562 polyA RNA-Seq 15.4
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 15.39
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 15.33
IRF1 regulates IFN dependent and independent gene expression 15.27
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 15.2
IRF2 is a master regulator of human keratinocyte stem cell fate 15.2
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 15.18
Survival of pancreatic cancer cells lacking KRAS function 15.08
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 15.08
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 15.01
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 14.99
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 14.98
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 14.98
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 14.95
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 14.95
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 14.94
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 14.87
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 14.75
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 14.75
Glioblastoma stem cells infected by ZIKA virus 14.68
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 14.67
CSL RNA-Seq on HKC and SCC cell lines 14.65
CSL 14.65
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 14.61
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 14.58
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 14.54
SLIGRL-induced gene expression changes in NHEK cells 14.48
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 14.42
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 14.36
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 14.22
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 14.2
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 14.14
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 14.13
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 14.0
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 14.0
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 13.99
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 13.99
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 13.95
Modeling Familial Cancer with iPSC Approaches 13.88
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 13.87
PGE2 mediated gene expression changes in human cervical stromal cells 13.86
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 13.86
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 13.75
Ribosomal footprinting of MDA-Parental and MDA-LM2 13.73
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 13.62
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 13.62
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 13.42
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 13.29
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 13.27
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 13.27
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 13.11
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 13.09
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 13.08
EWSR1 influences alternative splicing through direct and indirect mechanisms 13.07
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 13.05
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 13.03
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 13.02
Differential responses of human fetal brain neural stem cells to Zika virus infection 12.92
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 12.88
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 12.8
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 12.79
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 12.77
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 12.72
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 12.72
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 12.58
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 12.58
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 12.52
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 12.52
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 12.34
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 12.33
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 12.31
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 12.31
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 12.17
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 12.16
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 12.03
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 12.03
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 12.01
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 12.0
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 11.95
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 11.94
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 11.91
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 11.71
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 11.71
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 11.69
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 11.62
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 11.56
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 11.55
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 11.45
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 11.35
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 11.35
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 11.23
The MEF2B Regulatory Network 11.11
The MEF2B Regulatory Network - RNA-seq data 11.11
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 11.1
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 11.09
Identification of global regulators of T-helper cell lineage specification 11.09
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 11.02
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 11.0
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 10.91
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 10.84
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 10.77
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 10.75
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 10.68
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 10.66
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 10.65
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 10.63
Retinoic acid suppresses MYB in adenoid cystic carcinoma 10.5
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 10.5
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 10.45
U2AF1 mutations alter splice site recognition in hematological malignancies 10.39
Transcriptome landscape of HeLa response upon triamcinolone acetonide 10.15
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 10.12
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 9.96
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 9.93
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 9.91
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 9.82
Hepatitis C virus functionally sequesters miR-122 9.66
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 9.66
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 9.66
The contribution of Alu exons to the human proteome 9.54
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 9.54
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 9.44
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 9.4
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 9.35
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 9.35
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 9.35
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 9.35
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 9.31
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 9.23
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 9.16
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 9.09
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 9.09
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 9.07
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 9.0
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 8.98
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 8.96
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 8.95
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 8.95
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 8.61
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 8.61
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 8.54
p53 activity results in DNA replication fork processivity 8.47
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 8.44
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 8.44
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 8.35
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 8.28
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 8.2
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 8.18
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 8.14
Transcriptomic profiling of human peripheral blood-derived mast cells 8.04
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 8.04
Mitochondrial dsRNA triggers antiviral signalling in humans 8.01
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 7.92
Aneuploidy-induced cellular stresses limit autophagic degradation. 7.91
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 7.9
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 7.85
N6-methyladenine DNA Modification in Glioblastoma 7.85
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 7.82
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 7.82
Total RNA-seq in ALL-SIL upon TLX1 knockdown 7.72
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 7.71
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 7.67
Tyrosine Kinase Inhibitor Cardiotoxicity 7.67
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 7.44
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 7.29
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 7.27
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 7.22
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 7.07
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 7.01
oxLDL exposed trained monocytes 6.86
Transcriptomes of oxLDL exposed trained monocytes 6.86
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 6.61
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.57
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 6.5
RNA-seq of naive and primed ES cells (NHSM) 6.49
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 6.44
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 6.43
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 6.43
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 6.32
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 6.28
O-glcnAc reprograms cellular energetics 6.2
DIGIT regulates endoderm differentiation of human embryonic stem cells 6.16
BACH2 in human plasma cell fate decision 6.15
Expression profiles of the four human major ectodermal lineages 6.12
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 6.11
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 6.06
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.98
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 5.94
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 5.94
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.91
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 5.76
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 5.76
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 5.67
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 5.46
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 5.43
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 5.36
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 5.35
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 5.31
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 5.31
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 5.3
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 5.3
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 5.25
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.18
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 4.98
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 4.96
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 4.91
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 4.89
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 4.85
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.8
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 4.79
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 4.78
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 4.78
RNA-seq analysis upon ARID1B overexpression 4.72
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.51
DAOY-Notch1/Notch2 knockout: transcriptome comparison 4.49
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 4.41
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 4.33
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 4.28
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 4.18
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 4.15
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 4.06
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 4.03
Gene expression analysis in response to hypoxic pathway inhibition 3.96
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.89
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 3.85
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 3.73
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 3.65
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 3.61
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.6
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.59
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.56
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.48
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 3.47
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 3.46
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.36
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 3.33
Human ovarian granulosa cell transcriptome 3.25
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 3.13
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.13
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 3.06
Characterization of human ILC2 subsets 2.94
Gene expression changes due to PARP knockdown in human cells 2.88
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 2.84
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 2.8
Polarized B -cell functions 2.79
Effects of transcription on genome - nuclear lamina interactions 2.72
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 2.72
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.69
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.69
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 2.65
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.64
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.62
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.62
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 2.52
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 2.49
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.41
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.37
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.29
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.25
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 2.23
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.2
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.07
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.07
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 2.05
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 2.0
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 1.96
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.88
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.86
Leucegene: ALL sequencing 1.86
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.83
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.82
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.82
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.78
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.73
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.73
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 1.63
Trascriptome of thyroid cancer-induced macrophages 1.61
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 1.56
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 1.55
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.53
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.47
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 1.37
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.37
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.34
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.28
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.27
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.11
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.11
A code of mono-phosphorylation modulates the function of RB. 1.1
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.08
p63 controls the enhancer landscape during keratinocyte differentiation 1.07
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 1.07
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.05
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.02
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.02
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.92
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.86
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.84
Regulation of hypoxia-inducible factor activity by ZMYND8 0.81
Gene expressions of H9s in different culture systems 0.74
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 0.73
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.7
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.69
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.68
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.6
HBEC-shp53-PCHD7 0.55
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.55
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.52
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.47
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.46
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.31
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.23
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.09
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation